Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, ...

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

As researchers continue to explore more effective solutions, combining platelet-rich plasma (PRP) with fractional laser therapy has gained increasing attention.

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Jeffrey Casberg, M.S., of IPD Analytics and Luke Greenwalt, MBA, of IQVIA, both members of the Managed Healthcare Executive (MHE) editorial advisory board, will provide a midyear assessment of the ...

Esteban Gallardo, Pharm.D., said his career path changed after early mentorship showed him how managed care pharmacists could make a broader impact on a larger scale.

Chief of pharmacy at CareAllies. CareAllies is a population health company that supports physician practices and health plans.

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Medicare Advantage plans have drawn the ire of lawmakers for aggressive coding. Investigations are underway. Some hope ...

Lack of insurance, financial instability and even fear are potential reasons women may forego their cervical cancer screening ...